Eligibility may include confirming affiliation with recognized or approved organizations, validating the accuracy of information submitted, and identifying potential inconsistencies, misrepresentations, or falsification of account details
26% of retatrutide participants lost 30% of their body weight
You must meet certain BMI requirements (typically 27+ with weight-related comorbidity or 30+ without comorbidity) and have your prescription written for an FDA-approved indication
Off-Label Usage Investigated for weight management and obesity, though Wegovy (injectable semaglutide) is specifically approved for this
Many people who took Zepbound and drugs like it died or experienced severe complications such as gastroparesis, acute pancreatitis, and thyroid cancer
Sensations that should feel neutral feel uncomfortable or strange